ERBB2 and neoplasm: There was a reduction in phosphorylation of HER2 and HER3 in MMTV-NIC PTEN+/+ and MMTV-NIC PTEN+/− tumours following treatment with AZD8931 compared with vehicle-treated animals, although this did not reach statistical significance after histoscoring (Fig. 1E).